Marvin Slosman insider trades
Open-market stock purchases and sales by Marvin Slosman, Director at BioCardia, Inc, from SEC Form 4 filings since Jan 2, 2020.
Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -39%.
Open-market stock purchases and sales by Marvin Slosman, Director at BioCardia, Inc, from SEC Form 4 filings since Jan 2, 2020.
Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -39%.